Edited by Maria Isaguliants, Natalia Petrakova and Franco Buonaguro.
Volume 17 Supplement 1
Abstracts from “Chronic viral infection and cancer, openings for vaccines” virtual symposium of the TechVac Network
Symposium was sponsored by Riga Stradins University (RSU), Riga, Latvia; Peoples Friendship University of Russia (RUDN University); R&D companies "BD Biosciences" and "Helicon"; research journals "Infectious Agents and Cancer" (BMC, Spinger Nature) and "Cancers" (MDPI, Bazel) and by the Virtual Mobility Grant of the European Network of Vaccine Adjuvants ENOVA COST Action CA16231 to M. Isaguliants at RSU, Riga, Latvia.
VirtualDecember 16-17, 2021
Citation: Infectious Agents and Cancer 2022 17(Suppl 1):36
Infectious Agents and Cancer is affiliated with the African Organisation for Research & Training In Cancer (AORTIC)
- Editorial Board
- Manuscript editing services
- Instructions for Editors
- Editors' Profile
- Sign up for article alerts and news from this journal
Annual Journal Metrics
2022 Citation Impact
3.7 - 2-year Impact Factor
3.8 - 5-year Impact Factor
1.040 - SNIP (Source Normalized Impact per Paper)
0.583 - SJR (SCImago Journal Rank)
16 days submission to first editorial decision for all manuscripts (Median)
115 days submission to accept (Median)
1,550 Altmetric mentions
What is trending?
Click here to see which articles published in Infectious Agents and Cancer have been shared the most in the past three months.